Italian device reference-pricing suspended, back to the drawing board
This article was originally published in Clinica
Executive Summary
An Italian court has provisionally suspended the validity of the government’s planned medical device reference-pricing system after raising questions about the programme,. The move underlines a growing recognition by the regional and national healthcare authorities that the plans are fundamentally flawed and inoperable, as criticised by the medtech supplies industry from the outset.